0,855  0,009  Antiinflammatory
0,813  0,008  TNF expression inhibitor
0,806  0,007  CYP2C9 substrate
0,795  0,004  UGT1A6 substrate
0,787  0,003  Sulfotransferase substrate
0,776  0,010  Teratogen
0,768  0,005  Sensitization
0,761  0,004  UGT1A9 substrate
0,759  0,013  CYP3A4 substrate
0,751  0,011  Embryotoxic
0,735  0,003  UGT1A4 substrate
0,734  0,008  Respiratory analeptic
0,723  0,007  Aldehyde oxidase inhibitor
0,717  0,002  Contraceptive
0,732  0,020  Caspase 9 stimulant
0,718  0,007  CYP2C19 substrate
0,715  0,005  AR expression inhibitor
0,698  0,006  NOS3 expression inhibitor
0,690  0,002  Contraceptive male
0,704  0,030  Apoptosis agonist
0,675  0,002  UGT2B15 substrate
0,665  0,009  CTGF expression inhibitor
0,649  0,005  UDP-glucuronosyltransferase substrate
0,631  0,008  Antipruritic, allergic
0,626  0,003  UGT2B4 substrate
0,626  0,012  Analeptic
0,641  0,027  Transcription factor NF kappa B inhibitor
0,642  0,028  Antineoplastic (breast cancer)
0,621  0,010  Cytostatic
0,619  0,009  Hepatic disorders treatment
0,606  0,002  Lipocortins synthesis antagonist
0,605  0,006  UGT1A1 substrate
0,615  0,017  Cholesterol antagonist
0,610  0,016  Antihypercholesterolemic
0,594  0,015  Bone diseases treatment
0,579  0,012  Antiosteoporotic
0,570  0,010  Metabolic disease treatment
0,579  0,019  Carcinogenic
0,549  0,002  Contraceptive female
0,549  0,003  UGT2B7 substrate
0,557  0,013  NOS2 expression inhibitor
0,537  0,002  UGT2B9 substrate
0,550  0,015  Cardiovascular analeptic
0,549  0,015  Apoptosis antagonist
0,535  0,003  Cushing's syndrome treatment
0,549  0,016  Antineoplastic (pancreatic cancer)
0,532  0,004  Abortion inducer
0,530  0,005  Endometrios treatment
0,543  0,019  CYP1A2 substrate
0,529  0,006  Anesthetic general
0,524  0,021  CYP2D6 substrate
0,500  0,002  Androgen agonist
0,511  0,018  Proliferative diseases treatment
0,501  0,016  Nitric oxide antagonist
0,490  0,009  Antineoplastic (sarcoma)
0,513  0,037  Antibacterial
0,479  0,005  Sodium/bile acid cotransporter inhibitor
0,477  0,004  Estrogen agonist
0,497  0,025  Cytotoxic
0,473  0,003  Postmenopausal disorders treatment
0,477  0,011  Antineoplastic (liver cancer)
0,467  0,004  Antipruritic, non-allergic
0,471  0,008  Genotoxic
0,469  0,008  Prostatic (benign) hyperplasia treatment
0,471  0,014  Antihypertriglyceridemic
0,460  0,009  Melanin inhibitor
0,454  0,008  Prostate disorders treatment
0,465  0,019  ICAM1 expression inhibitor
0,480  0,036  Prostate cancer treatment
0,492  0,053  Antidiabetic
0,492  0,053  Cyclophilin D inhibitor
0,446  0,009  Hair growth stimulant
0,443  0,009  Interferon gamma antagonist
0,433  0,002  SULT1A1 substrate
0,451  0,023  Chemopreventive
0,470  0,050  Antineoplastic (lung cancer)
0,463  0,043  Immunosuppressant
0,432  0,013  P-glycoprotein inhibitor
0,428  0,010  UGT1A3 substrate
0,429  0,016  Calcium channel activator
0,421  0,010  Anesthetic
0,428  0,022  Antineoplastic (lymphoma)
0,438  0,037  Antineoplastic (ovarian cancer)
0,402  0,006  UGT2B1 substrate
0,426  0,030  Chemoprotective
0,398  0,005  Androgen antagonist
0,398  0,011  Antiacne
0,409  0,028  Hypoxia-inducible factor 1 alpha inhibitor
0,414  0,033  Antioxidant
0,401  0,024  Antihypoxic
0,382  0,006  Psychosexual dysfunction treatment
0,370  0,003  UGT2B10 substrate
0,373  0,007  Neurotrophic factor enhancer
0,382  0,017  Antimutagenic
0,362  0,002  RNA-directed RNA polymerase stimulant
0,379  0,024  Antineoplastic (endocrine cancer)
0,360  0,006  Antifungal enhancer
0,358  0,005  Neurotrophic factor
0,336  0,005  Estrogen antagonist
0,361  0,044  Antineoplastic (glioma)
0,328  0,012  Interleukin 6 antagonist
0,320  0,005  Aromatase inhibitor
0,320  0,005  Antineoplastic, alkylator
0,331  0,017  Pneumotoxic
0,338  0,027  GST M1-1 substrate
0,345  0,037  Antineoplastic (glioblastoma multiforme)
0,322  0,015  NOS3 expression enhancer
0,322  0,018  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,308  0,003  Progesterone antagonist
0,376  0,076  GST A substrate
0,361  0,062  Antineoplastic (colorectal cancer)
0,309  0,011  Toxic, respiratory center
0,322  0,024  Hepatoprotectant
0,315  0,019  Carcinogenic, group 3
0,354  0,060  Antineoplastic (colon cancer)
0,339  0,051  Interleukin 2 agonist
0,289  0,001  UGT2B11 substrate
0,284  0,003  Arachidonic acid antagonist
0,320  0,039  Antimitotic
0,317  0,038  DNA synthesis inhibitor
0,278  0,004  Growth stimulant
0,316  0,044  Heart failure treatment
0,284  0,015  Glutathione S-transferase substrate
0,269  0,002  Anabolic
0,269  0,002  Progesterone agonist
0,272  0,007  Choleretic
0,307  0,043  Mutagenic
0,278  0,016  Adenylate cyclase inhibitor
0,348  0,088  Antiobesity
0,262  0,004  Estrogen receptor alpha agonist
0,261  0,007  Menstruation disorders treatment
0,287  0,034  RNA-directed DNA polymerase inhibitor
0,262  0,010  Farnesoid X receptor antagonist
0,286  0,035  Antihypotensive
0,265  0,016  Cholesterol synthesis inhibitor
0,299  0,052  Antineoplastic (renal cancer)
0,252  0,007  Estrogen receptor beta antagonist
0,282  0,036  Growth hormone agonist
0,270  0,028  Diuretic
0,276  0,035  Peptidyltransferase inhibitor
0,275  0,034  VCAM1 expression inhibitor
0,248  0,008  Antirickettsial
0,304  0,065  Radioprotector
0,240  0,005  Adenylate cyclase stimulant
0,245  0,010  Microtubule formation inhibitor
0,236  0,002  Postcoital contraceptive
0,257  0,025  Protein kinase stimulant
0,290  0,059  Radiosensitizer
0,246  0,015  Antineoplastic antibiotic
0,233  0,004  Aldosterone antagonist
0,239  0,011  Alcohol dehydrogenase substrate
0,298  0,072  Antineoplastic (osteosarcoma)
0,296  0,070  Lipoprotein disorders treatment
0,273  0,052  Antiparasitic
0,286  0,066  Renal disease treatment
0,292  0,073  Antineoplastic (melanoma)
0,254  0,036  Eye irritation, high
0,299  0,081  Antineoplastic (brain cancer)
0,241  0,025  LDLR expression enhancer
0,221  0,007  Estrogen receptor alpha antagonist
0,322  0,109  CYP2C19 inhibitor
0,217  0,005  SULT1E1 substrate
0,293  0,082  Caspase 3 stimulant
0,215  0,004  Estrogen receptor beta agonist
0,254  0,045  Antiviral (Influenza)
0,212  0,004  Estradiol 17 beta-dehydrogenase inhibitor
0,210  0,003  Glucocorticoid antagonist
0,224  0,022  DNA polymerase I inhibitor
0,269  0,067  Antineoplastic (cervical cancer)
0,217  0,024  Antihyperlipoproteinemic
0,286  0,093  Mood disorders treatment
0,195  0,007  CDC25A inhibitor
0,271  0,086  Cardioprotectant
0,189  0,005  Premenstrual syndrome treatment
0,221  0,040  Antiviral (Herpes)
0,274  0,094  Antifungal
0,183  0,004  Anticholelithogenic
0,214  0,037  Antiviral (Influenza A)
0,215  0,041  Urolithiasis treatment
0,178  0,003  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,280  0,108  Vasodilator, peripheral
0,208  0,038  Lipid peroxidase inhibitor
0,280  0,112  Antileukemic
0,242  0,074  Angiogenesis stimulant
0,186  0,018  Antineoplastic alkaloid
0,170  0,002  SULT2A1 substrate
0,190  0,023  Expectorant
0,218  0,051  Age-related macular degeneration treatment
0,175  0,010  Ca2+-transporting ATPase inhibitor
0,205  0,041  Phospholipase C inhibitor
0,190  0,028  Antitussive
0,219  0,058  Antihelmintic
0,180  0,019  Mucolytic
0,166  0,006  5-Alpha-reductase inhibitor
0,244  0,084  DNA damaging
0,189  0,029  Alkylator
0,198  0,039  Phobic disorders treatment
0,178  0,020  Pregnane X receptor agonist
0,247  0,090  5 Hydroxytryptamine release stimulant
0,175  0,018  Antiinfertility, female
0,240  0,086  Interleukin agonist
0,236  0,084  Antipyretic
0,167  0,016  Actinic keratosis treatment
0,203  0,052  VEGF expression inhibitor
0,237  0,091  Flavin-containing monooxygenase substrate
0,316  0,172  Antineoplastic (solid tumors)
0,167  0,024  Interleukin 8 antagonist
0,242  0,100  Immunostimulant
0,182  0,040  Alpha-N-acetylglucosaminidase inhibitor
0,236  0,095  5 Hydroxytryptamine uptake stimulant
0,168  0,028  Coagulant
0,174  0,034  Antieczematic
0,170  0,030  Carcinogenic, group 2B
0,172  0,032  Cyclooxygenase 3 inhibitor
0,147  0,008  Glycine receptor antagonist
0,226  0,088  Tumour necrosis factor alpha release inhibitor
0,232  0,094  Cardiotonic
0,140  0,003  Hypogonadism treatment
0,169  0,034  Antihemorrhagic
0,243  0,109  FMO3 substrate
0,157  0,024  AMP-activated protein kinase stimulant
0,137  0,005  Mineralocorticoid receptor antagonist
0,177  0,046  Tubulin antagonist
0,182  0,051  Amylase inhibitor
0,152  0,022  Antispirochetal
0,147  0,016  Paget's disease treatment
0,174  0,044  SULT1A3 substrate
0,155  0,027  HDL-cholesterol increasing
0,137  0,009  Na+ K+ transporting ATPase inhibitor
0,131  0,004  Antihyperaldosteronism
0,164  0,043  Skin irritative effect
0,203  0,084  Nitric-oxide synthase stimulant
0,141  0,021  Antibiotic
0,202  0,084  Antialcoholic
0,117  0,003  Lipocortins synthesis agonist
0,231  0,118  Antidepressant
0,133  0,020  Antiviral (Trachoma)
0,203  0,092  Hypolipemic
0,166  0,056  Antineoplastic (squamous cell carcinoma)
0,138  0,028  Toll-Like receptor 4 antagonist
0,174  0,065  ATPase inhibitor
0,122  0,013  SULT1A2 substrate
0,120  0,012  Narcotic antagonist
0,149  0,043  Autism spectrum disorders treatment
0,138  0,033  UDP-glucose 4-epimerase inhibitor
0,220  0,119  Gastrin inhibitor
0,110  0,009  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,157  0,057  Movement disorders treatment
0,105  0,005  5-Alpha-reductase 2 inhibitor
0,175  0,077  Dual specificity phosphatase 3 inhibitor
0,145  0,049  Monophenol monooxygenase inhibitor
0,101  0,004  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,237  0,142  FMO1 substrate
0,096  0,005  Adenylate cyclase 1 inhibitor
0,115  0,024  Bile acid receptor antagonist
0,102  0,014  Antitreponemal
0,105  0,017  Alcohol oxidase inhibitor
0,186  0,099  Antiparkinsonian, rigidity relieving
0,091  0,004  Pregnane X receptor antagonist
0,157  0,071  Protein-tyrosine phosphatase inhibitor
0,099  0,013  Antimycoplasmal
0,143  0,059  Skin whitener
0,111  0,029  Tocolytic
0,090  0,010  Potassium channel Kv1.3 blocker
0,090  0,010  Andropause treatment
0,103  0,024  Antiviral (Dengue virus)
0,226  0,148  Antithrombotic
0,101  0,024  Estrogen-related receptor beta agonist
0,098  0,022  Glycine receptor agonist
0,114  0,040  Posttraumatic stress disorder treatment
0,128  0,057  Protein-tyrosine phosphatase 1B inhibitor
0,128  0,057  Antineoplastic antimetabolite
0,132  0,063  CC chemokine 6 receptor antagonist
0,106  0,038  Ornithine decarboxylase inhibitor
0,114  0,046  Creatine kinase inhibitor
0,104  0,035  Transcription factor NF kappa B stimulant
0,158  0,091  Tumour necrosis factor antagonist
0,072  0,006  5-Alpha-reductase 1 inhibitor
0,082  0,018  Hypercalcemia treatment
0,081  0,019  Protein 50S ribosomal subunit inhibitor
0,069  0,007  Microtubule stabilization
0,081  0,019  Alpha tubulin antagonist
0,095  0,034  Keratolytic
0,066  0,005  Glucose-6-phosphate dehydrogenase inhibitor
0,145  0,085  CF transmembrane conductance regulator agonist
0,064  0,006  Estrone sulfatase inhibitor
0,085  0,027  Beta tubulin antagonist
0,150  0,094  Dual specificity phosphatase inhibitor
0,224  0,169  Ulceration
0,112  0,060  Topoisomerase I inhibitor
0,056  0,004  Glucocorticoid agonist
0,090  0,038  T cell inhibitor
0,073  0,022  Heme oxygenase stimulant
0,093  0,042  Antiprotozoal activity enhancer
0,098  0,050  Triose-phosphate isomerase inhibitor
0,118  0,071  Antiviral (Influenza B)
0,053  0,007  Vanilloid 3 antagonist
0,054  0,008  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,048  0,003  Corticosteroid-like
0,067  0,023  Ryanodine receptor antagonist
0,063  0,020  Anesthetic inhalation
0,135  0,092  Antidiarrheal
0,143  0,103  Antipruritic
0,043  0,004  Hedgehog signaling activator
0,080  0,041  Phosphofructokinase-1 inhibitor
0,115  0,076  Aldehyde dehydrogenase inhibitor
0,204  0,166  Antihypertensive
0,039  0,001  Transcortin receptor antagonist
0,130  0,092  Antiprotozoal (Coccidial)
0,136  0,100  Aldose reductase substrate
0,080  0,045  Glutamate dehydrogenase inhibitor
0,045  0,010  Tubulin agonist
0,164  0,129  Free radical scavenger
0,036  0,002  Telomerase stimulant
0,102  0,070  Antihypermotility
0,064  0,033  Argininosuccinate synthase inhibitor
0,059  0,028  Alpha-mannosidase inhibitor
0,106  0,077  Photosensitizer
0,088  0,059  NADH dehydrogenase inhibitor
0,130  0,102  Sigma receptor agonist
0,099  0,072  Beta glucuronidase inhibitor
0,136  0,109  Muscular dystrophy treatment
0,079  0,053  Antidote, organophosphates
0,163  0,138  Antineoplastic (non-small cell lung cancer)
0,113  0,089  Retinoprotector
0,029  0,005  Progesterone receptor B antagonist
0,141  0,118  Aldehyde oxidase substrate
0,051  0,029  Glucose-6-phosphate isomerase inhibitor
0,041  0,020  Antibiotic Aminoglycoside-like
0,042  0,021  Farnesoid X receptor agonist
0,075  0,054  Analgesic, opioid
0,086  0,066  Potassium channel activator
0,042  0,022  Cholesterol absorption inhibitor
0,036  0,016  ATP citrate lysase inhibitor
0,027  0,009  Vitamin D receptor antagonist
0,113  0,096  Cocaine dependence treatment
0,020  0,003  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,039  0,022  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,022  0,007  Antibiotic Anthracycline-like
0,091  0,076  Chronic obstructive bronchitis treatment
0,047  0,034  Cholesterol esterase inhibitor
0,091  0,079  Antiviral (Poxvirus)
0,017  0,007  Antibiotic Tetracycline-like
0,023  0,014  GRP78 expression inhibitor
0,018  0,009  Vitamin D receptor agonist
0,014  0,004  Progesterone receptor A antagonist
0,056  0,048  Carbamoyl phosphate synthetase inhibitor
0,113  0,106  Vanilloid 1 agonist
0,042  0,036  Mannosidase inhibitor
0,129  0,125  Sedative
0,021  0,017  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,083  0,080  Glutamate release inhibitor
0,022  0,019  Protein 30S ribosomal subunit inhibitor
0,090  0,088  Adenylate kinase inhibitor
0,081  0,080  Prolactin inhibitor

